David Baker

23PUBLICATIONS
31CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)PharmacogenomicsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 19, 2025
Epstein-Barr virus and spontaneous lymphoblastoid cell lines: establishment, molecular characteristics, immune modulation, and therapeutic insight.

Adekunle A Adeniran, Gavin Giovannoni, David Baker

|Jun 27, 2025
Mechanistic biology linking traumatic brain injury to multiple sclerosis susceptibility.

David Baker, Lars Alfredsson, Anna Karin Hedström

|May 06, 2025
The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.

Gavin Giovannoni, Louisa James, Adekunle A Adeniran

|Dec 11, 2024
Effects of cladribine on intrathecal and peripheral B and plasma cells.

Kimberley Allen-Philbey, Sophie Stephenson, Gina Doody

|Jul 10, 2024
Delocalized quinolinium-macrocyclic peptides, an atypical chemotype for CNS penetration.

Valeria Pingitore, Jessica Pancholi, Thomas W Hornsby

|Sep 29, 2023
Organic solvents and Multiple Sclerosis: the doubled risk dilemma.

A Seaton, D Baker, A K Hedstrom

Pageof 4